NCT03187379View on ClinicalTrials.gov

Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 26, 2021

Study Completion Date

February 1, 2021

Conditions
Post-operative Pain Management
Interventions
DRUG

Exparel

Exparel liposomal bupivacaine - 20cc Exparel® + 60cc Bupivicaine

DRUG

Bupivacaine

60cc Bupivacaine

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Matthew Kroh

OTHER

NCT03187379 - Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler | Biotech Hunter | Biotech Hunter